DOI: https://doi.org/10.18370/2309-4117.2019.49.12-16

Strategy for prevention of uterine leiomyoma recurrence in combination with adenomiosis after organ-conserving operations in reproductive aged women

В. А. Потапов, В. І. Івах

Abstract


Aim of the study: to reduce the number of relapses and improve the reproductive function of women after surgical removal of uterine leiomyoma (LM).

Materials and methods: the study included 76 women of reproductive age who underwent organ-preserving surgical treatment for LM. Women were divided into two groups depending on the adenomyosis presence. Group I included 35 women with isolated LM, group II included 41 women with LM in combination with adenomyosis. Groups I and II were divided into 4 subgroups: in Ia and IIa subgroups during preparation for surgery patients received one of the agonists of gonadotropin releasing hormone (GnRH) for 3 months. In Ib and IIb subgroups suppressive therapy was not performed prior to surgical treatment. After a myomectomy women of I and II groups received one of the GnRH agonists for the first three months, followed by the low-dose combined oral contraceptive. The choice of funds was justified on the results of an immunohistochemical study of the Ki-67 antigen expression (proliferation marker), estrogen and progesterone receptors, and cyclooxygenase-2 (COX-2). Group IIb women were additionally prescribed non-hormonal therapy with fibrinolytic (streptokinase) and proteolytic (streptodornase) enzymes, as well as herbal antiproliferative agent containing indole-3-carbinol and epigallocatechin-3-gallate.

Results of the study: an immunohistochemical study showed that in women who did not receive suppressive therapy before surgery (Ib and IIb groups) Kі-67 antigen expression in the tumor nodes was significantly increased. Almost 2 times greater was the difference between the Ki-67 antigen expressions in the LM nodes with the adenomyosis combination. GnRH agonists did not inhibit the expression of estrogen and progesterone receptors. COX-2 expression was significantly higher than in intact myometrium. In women with combined uterine pathology the number of cells with a positive immunohistochemical reaction to COX-2 was 6.4 times higher than with isolated LM. Conclusions: myomectomy surgery only partially solves the problems of reproductive health restoration in women with combined uterine pathology. The proposed long-term suppressive therapy made it possible to reduce the tumor relapses number by almost 2.6 times after surgical organ-preserving treatment and to improve reproductive function in almost every third woman.


Keywords


uterine leiomyoma in combination with endometriosis; myomectomy; postoperative therapy; long-term surgery results; tumor recurrence

References


Vovk, I.B., Kondratiuk, V.K., Chubei, G.V., Zakharenko, N.F. “Treatment of genital endometriosis – from evolution to revolution (literature review).” Women’s Health 4 (2009): 40–3.

Vovk, I.B., Khomynska, Z.B., Zakharenko, N.F., et al. “Characteristics of hormonal status in women with endometriosis.” Women’s Health 10.56 (2010): 162–4.

Grek, L.P. “Features of systemic disorders in patients with genital endometriosis in combination with benign genital diseases and chronic pelvic pain syndrome.” Medical perspectives Vol. XXII-4 (2017): 62-7.

Guriev, T.D., Sidorova, I.S., Unanyan, A.L. The combination of uterine fibroids and adenomyosis. Moscow. MIA Ltd (2012): 256 p.

Damirov, M.M. Current management for patient with adenomyosis. Moscow. BINOM (2015).

Zakharenko, N.F. “Clinical and anamnestic characteristics of women with different forms of endometriosis.” Pediatrics, Obstetrics and Gynecology: Scientific and Practical Journal 72.5 (2010): 97–104.

Zakharenko, N.F., Kovbasii, V.P., Kovalenko, N.V. “Characteristics of psychological personality types in benign hyperproliferative diseases of the female reproductive system.” Women’s Health 2.48 (2010): 133–6.

Kudinova, N.N., Frolov, M.V., Naumov, N.V., Shurshukov, Y.Y. “Medical and social characteristics of women with uterine myoma in combination with adenomyosis.” Electronic journal “Postgraduate doctor”. Available from: [http://vrach-aspirant.ru/article/ gynecology/13525], last accessed Oct 22, 2019.

Patent for useful model № 54872 Ukraine.Method for postoperative rehabilitation and pregrevidas preparation after conservative myomectomy / Potapov, V.O., Medvedev, M.V., Polschikov, P.I., Stepanova, D.Y., Finkova, O.P., No. u 2010 06592; appl. 31.05.2010, pub. 25.11.2010, bull. No. 22.

Patent for useful model № 85891 Ukraine. Method of treatment of hyperproliferative states of the pelvic organs / Potapov, V.O., Hryschenko, O.V., Medvedev, M.V., et al., No. u 2013 04798; appl. 15.04.2013, pub. 10.12.2013, bul. No. 23.

Potapov, V.A., Мedvedev, М.V., Ivakh, V.I. “Strategies for the therapy of endometriosis disease in combination with the uterine body leiomyoma.” Journal of Obstetrics and Women's Diseases Vol. LХI special edition (2012): 26–7.

Strizhakov, A.N., Davydov, A.I., Pashkov, V.M., Lebedev, V.A. Benign uterine diseases. Moscow. GEOTAR-Media (2012): 288 p.

Tatarchuk, T.F., Zakharenko, N.F., Tutchenko, T.N. “New approaches to the problematic issues of treatment of genital endometriosis.” Reproductive Endocrinology 3 (2013): 36–45.

Tatarchuk, T.F., Zakharenko, N.F., Manoliak, I.P., Kovbasii, V.P. “Improving medical tactics in women with endometriosis.” Reproductive Endocrinology 4.18 (2014): 24–7.

Tatarchuk, T.F.., Zakharenko, N.F.., Manoliak, I.P., et al. “Features of climacteric syndrome in women with endometriosis and possible ways of its correction.” Scientific journal of the MOH of Ukraine 2 (2014): 71–8.

Fadeeva, N.I., Yavorskaya, S.D., Dolina, O.V., et al. “Adenomyosis: new therapeutic options.” Medical news 5 (2017): 13–15.

Adamson, G.D., Pasta, D.J. “Endometriosis fertility index: the new, validated endometriosis staging system.” Fertil Steril 94 (2010): 1609–15.

Bayoglu, T.Y., Dilbaz, B., Altinbas, S.K., Dilbaz, S. “Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue.” Fertil Steril 95 (2011): 492–6.

Brosens, I., Brosens, J.J., Fusi, L., et al. “Risks of adverse pregnancy outcome in endometriosis.” Fertil Steril 98 (2012): 30–5.

Brown, J., Pan, A., Hart, R.J. “Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.” Cochrane Database Syst Rev 12 (2010): CD008475.

de Ziegler, D., Gayet, V., Aubriot, F.X., et al. “Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes.” Fertil Steril 94 (2010): 2796–9.

Fagervold, B., Jenssen, M., Hummelshoj, L., Moen, M.H. “Life after a diagnosis with endometriosis – a 15 years follow-up study.” Acta Obstet Gynecol Scand 88 (2009): 914–9.

Giudice, L.C. “Clinical practice: endometriosis.” N Engl J Med 362 (2010): 2389–98.

Guo, S.W. “Recurrence of endometriosis and its control.” Hum Reprod Update 15 (2009): 441–61.

Laschke, M.W., Menger, M.D. “Anti-angiogenetic treatment strategies for the therapy of endometriosis.” Hum Reprod Update 18 (2012): 682–702.

Shakiba, K., Bena, J.F., McGill, K.M., et al. “Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery.” Obstet Gynecol 111 (2008): 1285–92.

Stratton, P., Berkley, K.J. “Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications.” Hum Reprod Update 17 (2011): 327–46.


GOST Style Citations


1.         Вовк, І.Б. Лікування генітального ендометріозу – від еволюції до революції (огляд літератури) / І.Б. Вовк, В.К. Кондратюк, Г.В. Чубей, Н.Ф. Захаренко // Здоровье женщины. – 2009. – № 4. – С. 40–43.

2.         Вовк, І.Б. Характеристика гормонального статусу в жінок із ендометріозом / І.Б. Вовк, З.Б. Хоминська, Н.Ф. Захаренко, О.Ф. Трохимович, В.П. Ковбасій // Здоровье женщины. – 2010. – № 10 (56). – С. 162–164.

3.         Грек, Л.П. Особливості системних порушень у пацієнток з генітальним ендометріозом у поєднанні з доброякісними захворюваннями геніталій та синдромом хронічного тазового болю / Л.П. Грек // Медичні перспективи. – 2017. – Т.XXII-4. – С.62–67.

4.         Гуриев, Т.Д. Сочетание миомы матки и аденомиоза / Т.Д. Гуриев, И.С. Сидорова, А.Л. Унанян. – М.: ООО «МИА», 2012. – 256 с.

5.         Дамиров, М.М. Современная тактика ведения больных с аденомиозом: практическое руководство / М.М. Дамиров. – М.: Издательство БИНОМ, 2015.

6.         Захаренко, Н.Ф. Клініко-анамнестична характеристика жінок із різними формами ендометріозу / Н.Ф. Захаренко // Педіатрія, акушерство та гінекологія. – 2010. – Т. 72, № 5. – С. 97–104.

7.         Захаренко, Н.Ф. Характеристика психологических типов личности при доброкачественных гиперпролиферативных заболеваниях репродуктивной системы женщины / Н.Ф. Захаренко, В.П. Ковбасий, Н.В. Коваленко // Здоровье женщины. – 2010. – № 2 (48). – С. 133–136.

8.         Кудинова, Н.Н. Медико-социальная характеристика женщин с миомой матки в сочетании с аденомиозом / Н.Н. Кудинова, М.В. Фролов, Н.В. Наумов, Ю.Ю. Шуршуков // Электронный журнал «Врач-аспирант».

9. Патент на корисну модель № 54872 України. Спосіб післяопераційної реабілітації та прегравідарної підготовки після консервативної міомектомії / В.О. Потапов, М.В. Медведєв, П.І. Польщіков, Д.Ю. Степанова, О.П. Фінкова. – № u 2010 06592; заяв. 31.05.2010, опубл. 25.11.2010, бюл. № 22.

10.       Патент на корисну модель № 85891 України. Спосіб лікування гіперпроліферативних станів органів малого таза / В.О. Потапов, О.В. Грищенко, М.В. Медведєв та ін. – № u 2013 04798; заяв. 15.04.2013, опубл. 10.12.2013, бюл. № 23.

11.       Потапов, В.А. Стратегии терапии эндометриоидной болезни в сочетании с лейомиомой тела матки / В.А. Потапов, В.М. Медведeв, В.И. Ивах // Журналъ акушерства и женскихъ болезней. – 2012. – Т. LХI, спец. вып. – С. 26–27.

12.       Стрижаков, А.Н. Доброкачественные заболевания матки / А.Н. Стрижаков, А.И. Давыдов, В.М. Пашков, В.А. Лебедев // М.: ГЭОТАР-Медиа, 2012. – 288 с.

13.       Татарчук, Т.Ф. Новые подходы к проблемным вопросам лечения генитального эндометриоза / Т.Ф. Татарчук, Н.Ф. Захаренко, Т.Н. Тутченко // Репродуктивная эндокринология. – 2013. – № 3. – С. 36-45.

14.       Татарчук, Т.Ф. Удосконалення лікувальної тактики ведення жінок із ендометріозом / Т.Ф. Татарчук, Н.Ф. Захаренко, І.П. Маноляк, В.П. Ковбасій // Репродуктивна ендокринологія. – 2014. – № 4 (18). – С. 24–27.

15.       Татарчук, Т.Ф. Особенности проявления климактерического синдрома у женщин с эндометриозом и возможные пути его коррекции / Т.Ф. Татарчук, Н.Ф. Захаренко, И.П. Маноляк, Н.В. Коваленко, В.П. Ковбасий // Науковий журнал МОЗ України. – 2014. – № 2. – С. 71–78.

16.       Фадеева, Н.И. Аденомиоз. Новые возможности терапии / Н.И. Фадеева, С.Д. Яворская, О.В. Долина и др. // Медицинские новости. – 2017. – № 5. – С. 13–15.

17.       Adamson, G.D., Pasta, D.J. “Endometriosis fertility index: the new, validated endometriosis staging system.” Fertil Steril 94 (2010): 1609–15.

18.       Bayoglu, T.Y., Dilbaz, B., Altinbas, S.K., Dilbaz, S. “Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue.” Fertil Steril 95 (2011): 492–6.

19.       Brosens, I., Brosens, J.J., Fusi, L., et al. “Risks of adverse pregnancy outcome in endometriosis.” Fertil Steril 98 (2012): 30–5.

20.       Brown, J., Pan, A., Hart, R.J. “Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.” Cochrane Database Syst Rev 12 (2010): CD008475.

21.       de Ziegler, D., Gayet, V., Aubriot, F.X., et al. “Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes.” Fertil Steril 94 (2010): 2796–9.

22.       Fagervold, B., Jenssen, M., Hummelshoj, L., Moen, M.H. “Life after a diagnosis with endometriosis – a 15 years follow-up study.” Acta Obstet Gynecol Scand 88 (2009): 914–9.

23.       Giudice, L.C. “Clinical practice: endometriosis.” N Engl J Med 362 (2010): 2389–98.

24.       Guo, S.W. “Recurrence of endometriosis and its control.” Hum Reprod Update 15 (2009): 441–61.

25.       Laschke, M.W., Menger, M.D. “Anti-angiogenetic treatment strategies for the therapy of endometriosis.” Hum Reprod Update 18 (2012): 682–702.

26.       Shakiba, K., Bena, J.F., McGill, K.M., et al. “Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery.” Obstet Gynecol 111 (2008): 1285–92.

27.       Stratton, P., Berkley, K.J. “Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications.” Hum Reprod Update 17 (2011): 327–46.





Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)